Rizzi, M.; D’Onghia, D.; Tonello, S.; Minisini, R.; Colangelo, D.; Bellan, M.; Castello, L.M.; Gavelli, F.; Avanzi, G.C.; Pirisi, M.;
et al. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters. Int. J. Mol. Sci. 2023, 24, 7099.
https://doi.org/10.3390/ijms24087099
AMA Style
Rizzi M, D’Onghia D, Tonello S, Minisini R, Colangelo D, Bellan M, Castello LM, Gavelli F, Avanzi GC, Pirisi M,
et al. COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters. International Journal of Molecular Sciences. 2023; 24(8):7099.
https://doi.org/10.3390/ijms24087099
Chicago/Turabian Style
Rizzi, Manuela, Davide D’Onghia, Stelvio Tonello, Rosalba Minisini, Donato Colangelo, Mattia Bellan, Luigi Mario Castello, Francesco Gavelli, Gian Carlo Avanzi, Mario Pirisi,
and et al. 2023. "COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters" International Journal of Molecular Sciences 24, no. 8: 7099.
https://doi.org/10.3390/ijms24087099
APA Style
Rizzi, M., D’Onghia, D., Tonello, S., Minisini, R., Colangelo, D., Bellan, M., Castello, L. M., Gavelli, F., Avanzi, G. C., Pirisi, M., & Sainaghi, P. P.
(2023). COVID-19 Biomarkers at the Crossroad between Patient Stratification and Targeted Therapy: The Role of Validated and Proposed Parameters. International Journal of Molecular Sciences, 24(8), 7099.
https://doi.org/10.3390/ijms24087099
